» Articles » PMID: 11554695

Immune Disorders in Women with Premature Ovarian Failure in Initial Period

Overview
Date 2001 Sep 14
PMID 11554695
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Problem: Premature ovarian failure (POF) may be considered as an autoimmune endocrine disease. Autoantibodies and lymphocyte subset changes are associated with premature ovarian failure. Immune cell parameters were studied in relation with anticardiolipin antibodies (ACAB) classes M and G in the initial period of POF.

Methods: Two-color flow cytometry was used to determine lymphocyte subsets and enzyme-linked immunosorbent assay (ELISA) was used to detect ACAB and hormones in the peripheral blood of 68 POF patients, 32 women with normal menopause (NM) and 13 healthy women as a normal control (NC).

Results: Patients in the initial period of POF had decreased levels of CD3+, CD19+, CD3+8+, and CD8+57+ lymphocytes and a high percentage of CD5 positive in CD19+ cell population compared to the control; frequencies of IgM ACAB in POF patients were significantly higher than both IgG ACAB and IgM ACAB in NC; correlation between lymphocyte subsets and hormone levels was absent. Women with early NM showed a low number of CD3+, CD3+4+, and CD3+8+ lymphocytes, a high number of CD3 + DR, and elevation of the percentage of CD5 positive in CD19+ lymphocytes compared with the control. The frequencies of both IgM and IgG ACAB were high; the levels of lymphocyte subsets had correlations with progesterone and estradiol concentrations.

Conclusions: An increase of autoantibody producing B cells (CD5+19+) and a low number of effector suppressor/cytotoxic lymphocytes (CD8+57+) with active production of anticardiolipin autoantibodies class M were found. This suggested a primary autoimmune process in the initial period of POF. Autoimmune defeat of the ovary could be the primary cause of POF, whereas in NM autoimmunity is a result of hormone dysfunction.

Citing Articles

Analysis of post-transcriptional regulatory signatures and immune cell subsets in premature ovarian insufficiency based on full-length transcriptome.

Yu Z, Zhang X, Nong Y, Ding H, Fu X, Li F Sci Rep. 2025; 15(1):5533.

PMID: 39953072 PMC: 11829046. DOI: 10.1038/s41598-025-89391-5.


Integrative bioinformatics analysis for identifying the mitochondrial-related gene signature associated with immune infiltration in premature ovarian insufficiency.

Lu M, Li W, Zhou J, Shang J, Lin L, Liu Y BMC Med. 2024; 22(1):444.

PMID: 39379953 PMC: 11462806. DOI: 10.1186/s12916-024-03675-7.


The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities.

Shen L, Liu J, Luo A, Wang S J Ovarian Res. 2023; 16(1):237.

PMID: 38093329 PMC: 10717903. DOI: 10.1186/s13048-023-01300-4.


Vitamin D and the Immune System in Menopause: A Review.

Min J, Jo H, Chung Y, Song J, Kim M, Kim M J Menopausal Med. 2022; 27(3):109-114.

PMID: 34989184 PMC: 8738846. DOI: 10.6118/jmm.21011.


Research Progress on the Treatment of Premature Ovarian Failure Using Mesenchymal Stem Cells: A Literature Review.

Wang J, Liu W, Yu D, Yang Z, Li S, Sun X Front Cell Dev Biol. 2021; 9:749822.

PMID: 34966738 PMC: 8710809. DOI: 10.3389/fcell.2021.749822.